Three Complete Responses in Azer-Cel Allogeneic CD19 CAR T Phase 1b Trial in Blood Cancer (Diffuse Large B-Cell Lymphoma) Three complete responses in azer-cel allogeneic CD19 CAR T Phase 1b trial in blood cancer (Diffuse Large B-Cell Lymphoma)

CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Immuneering to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference Immuneering to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

ImCheck Awarded EUR 20.18 Million from the French Government Through the France 2030 Investment and Innovation Plan FOR IMMEDIATE RELEASE -- ImCheck secures substantial non-dilutive funding to accelerate the progress of two breakthrough programs in cancer and infectious diseases, in support of France's 2030...

Roc Solid Foundation Kicks Off Childhood Cancer Awareness Month With National ‘Play Defeats Cancer Tour’, Building Close to 80 Playsets and Playhouses for Kids Fighting Cancer in Just Three Days CHESAPEAKE, Va., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Roc Solid Foundation, a nonprofit organization that provides kids across the country who are fighting cancer with backyard playsets, will kick off...